Regentatlantic Capital LLC Stryker Corp Transaction History

Regentatlantic Capital LLC

$3.34 Billion
Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Stryker Corp stock. As of the latest transaction made, Regentatlantic Capital LLC holds 29,341 shares of SYK stock, worth $10.7 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

29,341

Previous 28,421 3.24%

Holding current value

$10.7 Million

Previous $5.65 Million 5.11%

% of portfolio

0.18%

Previous 0.19%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$189.27 - $231.83 $174,128 - $213,283	920 Added 3.24%	29,341 $5.94 Million
Q2 2022 Aug 15, 2022	BUY	$194.09 - $276.37 $148,284 - $211,146	764 Added 2.76%	28,421 $5.65 Million
Q1 2022 May 02, 2022	BUY	$245.33 - $277.77 $875,582 - $991,361	3,569 Added 14.82%	27,657 $7.39 Million
Q4 2021 Jan 27, 2022	BUY	$236.63 - $276.44 $160,198 - $187,149	677 Added 2.89%	24,088 $6.44 Million
Q3 2021 Nov 15, 2021	BUY	$248.9 - $280.09 $227,245 - $255,722	913 Added 4.06%	23,411 $6.17 Million
Q2 2021 Aug 12, 2021	BUY	$242.95 - $267.0 $413,500 - $454,434	1,702 Added 8.18%	22,498 $5.84 Million
Q1 2021 Apr 29, 2021	BUY	$221.01 - $248.82 $234,270 - $263,749	1,060 Added 5.37%	20,796 $5.07 Million
Q4 2020 Feb 04, 2021	BUY	$202.01 - $245.04 $161,203 - $195,541	798 Added 4.21%	19,736 $4.84 Million
Q3 2020 Oct 13, 2020	SELL	$177.77 - $215.81 $19,732 - $23,954	-111 Reduced 0.58%	18,938 $3.95 Million
Q2 2020 Aug 13, 2020	BUY	$144.67 - $207.03 $84,342 - $120,698	583 Added 3.16%	19,049 $3.43 Million
Q1 2020 May 14, 2020	SELL	$126.5 - $225.1 $10,499 - $18,683	-83 Reduced 0.45%	18,466 $3.07 Million
Q4 2019 Feb 04, 2020	SELL	$197.98 - $220.53 $28,113 - $31,315	-142 Reduced 0.76%	18,549 $3.89 Million
Q3 2019 Oct 22, 2019	SELL	$205.4 - $221.82 $104,754 - $113,128	-510 Reduced 2.66%	18,691 $4.04 Million
Q2 2019 Jul 23, 2019	SELL	$180.24 - $205.58 $8,651 - $9,867	-48 Reduced 0.25%	19,201 $3.95 Million
Q1 2019 May 03, 2019	SELL	$152.46 - $198.0 $64,490 - $83,754	-423 Reduced 2.15%	19,249 $3.8 Million
Q4 2018 Jan 30, 2019	SELL	$145.0 - $178.65 $78,300 - $96,471	-540 Reduced 2.67%	19,672 $3.08 Million
Q3 2018 Oct 30, 2018	SELL	$163.25 - $177.68 $16,325 - $17,768	-100 Reduced 0.49%	20,212 $3.59 Million
Q2 2018 Jul 31, 2018	SELL	$155.17 - $179.78 $26,378 - $30,562	-170 Reduced 0.83%	20,312 $3.43 Million
Q1 2018 Apr 23, 2018	SELL	$148.01 - $168.91 $55,355 - $63,172	-374 Reduced 1.79%	20,482 $3.3 Million
Q4 2017 Jan 23, 2018	SELL	$143.51 - $159.74 $75,342 - $83,863	-525 Reduced 2.46%	20,856 $3.23 Million
Q3 2017 Oct 25, 2017	BUY	$138.36 - $147.87 $2.96 Million - $3.16 Million	21,381	21,381 $3.04 Million

Others Institutions Holding SYK

# of Institutions

2,231

Shares Held

284M

Call Options Held

1.35M

Put Options Held

1.6M

View Full List

About STRYKER CORP

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $138B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

More about SYK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Account

Regentatlantic Capital LLC Stryker Corp Transaction History